Intravenous CannulationPEDVEINNCT07279701
The Effect of Near-infrared Spectroscopy on the Success of Peripheral Venous Access
A study testing Use of near-infrared imaging by VeinViewer Flex of periferal veins in people with Intravenous Cannulation, run by Brno University Hospital at 1 site in Czechia.
Trial summary
The goal of this clinical trial is to learn if using near-infrared imaging in pediatric vein cannulation is leading to higher success rate. The main question it aims to answer is: is there higher success of first attempt in periferal vein cannulation? does it lower overall number of attempts to successful cannulation? Read more about this study
- Who is it for?
- Ages 0 days to 19 years
- Conditions the study is for
- Intravenous Cannulation
- What is being tested?
- Use of near-infrared imaging by VeinViewer Flex of periferal veins
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 200 participants
- Where
- 1 siteCzechia
- Study dates
- 15 Dec 2025to 31 Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 0 days to 19 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- Pediatric patients admitted to the inpatient section of the Department of Pediatric Anesthesiology and Resuscitation, Brno University Hospital
- Pediatric patients in the anesthesia section of the Department of Pediatric Anesthesiology and Resuscitation, Brno University Hospital
- Indicated insertion of peripheral venous access
- Consent of the patient/legal representative to the study
Who cannot join
- Disagreement with the study
- Not indicated insertion of peripheral venous access (according to clinical condition and decision of the attending physician)
- A device for near-infrared imaging of the venous bed is not available
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Czechia1 site, 1 recruiting
- Recruiting
University Hospital Brno
Brno, South Moravian, 60200
Hana Harazim, 777146704, hana.harazim@gmail.com
About this study
Official title: The Effect of Near-infrared Spectroscopy on the Success of Peripheral Venous Access: a Pilot Randomized Controlled Study
The goal of this clinical trial is to learn if using near-infrared imaging in pediatric vein cannulation is leading to higher success rate. The main question it aims to answer is:
is there higher success of first attempt in periferal vein cannulation? does it lower overall number of attempts to successful cannulation?
Read the detailed description
Providing venous access in pediatric anesthesia and intensive care is among the basic and necessary interventions for blood sampling and administration of drugs and possibly transfusion products and derivatives.
In anesthesia, effective provision of venous access is a prerequisite for safe anesthesia. In pediatric patients and newborns, provision of venous access is complicated by patient non-cooperation, but primarily by the smaller diameter of the vessels and often limited possibility of direct visualization, or limited possibility of palpation of the vessel under visual control. Ultrasound is currently used to facilitate provision of IV access, however, imaging under the USG probe and its subsequent puncture requires high skill of medical personnel and is preferentially applied by medical staff in the conditions of the Czech Republic. Near-infrared imaging (IR) allows direct visualization of superficial vascular bed and may potentially be associated with higher puncture success rates (higher first attempt success, reduction of total attempts).
- Conditions
- Intravenous Cannulation
- Being tested
- Use of near-infrared imaging by VeinViewer Flex of periferal veins
- Keywords
- pediatric, near-infrared imaging, periferal vein cannulation, difficult intravenous access
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Use of near-infrared imaging by VeinViewer Flex of periferal veinsDevice
The projected near-infrared light is absorbed by the blood and reflected by surrounding tissue, captured, processed, and digitally projected in real time directly onto the skin surface. It provides an accurate, real-time image of the patient's blood pattern.
Patented VeinViewer technology using AVIN™ (Active Vascular Imaging Navigation) allows the blood vessels to be seen down to a depth of 10 mm. With VeinViewer, physicians can see peripheral veins, bifurcations, and valves and assess venous filling/flushing in real time.
| Study group | Role | What they receive |
|---|---|---|
| VeinViewer Flex | Experimental | The periferal vein cannulation will be aided by concurrent near-infrared imaging by device VeinViewer Flex using AVIN™ (Active Vascular Imaging Navigation). Receives: Device: Use of near-infrared imaging by VeinViewer Flex of periferal veins |
| Landmark | No intervention | The peripheral vein cannulatoon will be provided by usual landmark technique, without any other imaging device. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Success rate of first attempt in peripheral vein cannulation
Success rate of first attempt in periferal vein cannulation
Measured: Periprocedural
Number of attempts
Overall number of attempts needed to secure periferal vein access
Measured: Periprocedural
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Dec 2025
- Study start15 Dec 2025
- Primary completion31 Dec 2026 (estimated)
- Study completion31 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Intravenous CannulationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Brno University Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Petr Štourač, MD, Brno University Hospital
- Investigators
- Petr Štourač, prof, MD, PhD, Principal investigator, Brno University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07279701
- Sponsor's protocol ID
- PEDVEIN
- Acronym
- PEDVEIN
- Status last verified
- Feb 2026
- First submitted
- 17 Nov 2025
- Last updated
- 27 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 27 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Near-infrared Spectroscopy on the Success of Peripheral Venous Access: a Pilot Randomized Controlled Study
- ClinicalTrials.gov ID
- NCT07279701
- Acronym / sponsor ID
- PEDVEIN / PEDVEIN
- Conditions
- Intravenous Cannulation
- Keywords
- pediatric, near-infrared imaging, periferal vein cannulation, difficult intravenous access
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- Brno University HospitalUniversity, hospital or other
- Study start
- 15 Dec 2025 (actual)
- Primary completion
- 31 Dec 2026 (estimated)
- Study completion
- 31 Dec 2026 (estimated)
- First posted
- 12 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to learn if using near-infrared imaging in pediatric vein cannulation is leading to higher success rate. The main question it aims to answer is:
is there higher success of first attempt in periferal vein cannulation? does it lower overall number of attempts to successful cannulation?
Detailed description
Providing venous access in pediatric anesthesia and intensive care is among the basic and necessary interventions for blood sampling and administration of drugs and possibly transfusion products and derivatives.
In anesthesia, effective provision of venous access is a prerequisite for safe anesthesia. In pediatric patients and newborns, provision of venous access is complicated by patient non-cooperation, but primarily by the smaller diameter of the vessels and often limited possibility of direct visualization, or limited possibility of palpation of the vessel under visual control. Ultrasound is currently used to facilitate provision of IV access, however, imaging under the USG probe and its subsequent puncture requires high skill of medical personnel and is preferentially applied by medical staff in the conditions of the Czech Republic. Near-infrared imaging (IR) allows direct visualization of superficial vascular bed and may potentially be associated with higher puncture success rates (higher first attempt success, reduction of total attempts).
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| VeinViewer Flex | Experimental | Device: Use of near-infrared imaging by VeinViewer Flex of periferal veinsThe periferal vein cannulation will be aided by concurrent near-infrared imaging by device VeinViewer Flex using AVIN™ (Active Vascular Imaging Navigation). |
| Landmark | No intervention | –The peripheral vein cannulatoon will be provided by usual landmark technique, without any other imaging device. |
Who may qualify
- Ages
- 0 days to 19 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (4 listed)
- Pediatric patients admitted to the inpatient section of the Department of Pediatric Anesthesiology and Resuscitation, Brno University Hospital
- Pediatric patients in the anesthesia section of the Department of Pediatric Anesthesiology and Resuscitation, Brno University Hospital
- Indicated insertion of peripheral venous access
- Consent of the patient/legal representative to the study
Key exclusion criteria (3 listed)
- Disagreement with the study
- Not indicated insertion of peripheral venous access (according to clinical condition and decision of the attending physician)
- A device for near-infrared imaging of the venous bed is not available
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Use of near-infrared imaging by VeinViewer Flex of periferal veinsThe projected near-infrared light is absorbed by the blood and reflected by surrounding tissue, captured, processed, and digitally projected in real time directly onto the skin surface. It provides an accurate, real-time image of the patient's blood pattern. Patented VeinViewer technology using AVIN™ (Active Vascular Imaging Navigation) allows the blood vessels to be seen down to a depth of 10 mm. With VeinViewer, physicians can see peripheral veins, bifurcations, and valves and assess venous filling/flushing in real time. | Device | VeinViewer Flex |
Primary outcome
Success rate of first attempt in peripheral vein cannulation
Time frame: Periprocedural
Success rate of first attempt in periferal vein cannulation
Number of attempts
Time frame: Periprocedural
Overall number of attempts needed to secure periferal vein access
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Feb 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Intravenous Cannulation
Recruiting
Ultrasound-Guided Electrical Dry Needling for Chronic Cervical Radiculopathy
Cervical Radiculopathy
Enrolling by invitation
TruVascular Access - Ultrasound-Guided Vascular Access Study
Peripheral Venous Catheterization, Difficult Intravenous Access
Recruiting
Dry Needling in Multiple Sclerosis
Multiple Sclerosis
RecruitingObservational study
Frailty and Ultrasound-Guided Central Venous Catheterization Difficulty in Adult Cardiac Surgery Patients
Frailty, Cardiac Surgery
Not yet recruiting
Dry Needling and Quad Strength After Anterior Cruciate Ligament Reconstruction
Anterior Cruciate Ligament Reconstruction Rehabilitation, Dry Needling
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Petr Štourač, prof, MD, PhD principal investigator
Brno University Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Use of near-infrared imaging by VeinViewer Flex of periferal veins in people with Intravenous Cannulation, run by Brno University Hospital at 1 site in Czechia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 27 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Czechia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Hana Harazim, MD, PhD (+420777146704, harazim.hana@fnbrno.cz), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Success rate of first attempt in peripheral vein cannulation (time frame: Periprocedural). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Feb 2026.